Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada
暂无分享,去创建一个
A. Gates | M. Gates | L. Hartling | J. Pillay | B. Zakher | A. Wingert | S. Guitard | S. Rahman
[1] J. McKenzie,et al. Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition , 2022, Journal of public health.
[2] F. McAlister,et al. Informing COVID-19 vaccination priorities based on the prevalence of risk factors among adults in Canada , 2021, Canadian Medical Association Journal.
[3] J. Chevinsky,et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19 , 2021, JAMA network open.
[4] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[5] Ton Dofferhoff,et al. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis , 2021, PloS one.
[6] B. Nørgård,et al. Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark , 2021, Journal of Autoimmunity.
[7] D. Donà,et al. Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results from an Italian Multicenter Study , 2020, SSRN Electronic Journal.
[8] S. Henrickson,et al. Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19 , 2021, The Journal of Allergy and Clinical Immunology: In Practice.
[9] E. Klang,et al. Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19 , 2021, ACR open rheumatology.
[10] P. Lochhead,et al. Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden , 2021, United European gastroenterology journal.
[11] I. Larsson,et al. The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality , 2021, Acta anaesthesiologica Scandinavica.
[12] Shenae Samuels,et al. The Epidemiology and Predictors of Outcomes Among Confirmed COVID-19 Cases in a Large Community Healthcare System in South Florida , 2021, Journal of Community Health.
[13] Samuel D. Butensky,et al. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients , 2020, American Journal of Transplantation.
[14] Yuehua Wu,et al. Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries , 2020, The Journal of infectious diseases.
[15] F. Figueras,et al. Pregnant women with SARS‐CoV‐2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx) , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[16] F. Mohseni,et al. β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study , 2020, Hemoglobin.
[17] L. Poon,et al. Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program , 2020, American Journal of Obstetrics and Gynecology.
[18] R. Clere-Jehl,et al. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] T. Luu,et al. Clinical Characteristics and Disease Severity Among Infants With SARS-CoV-2 Infection in Montreal, Quebec, Canada , 2020, JAMA network open.
[20] F. Baldanti,et al. Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 , 2020, Scientific Reports.
[21] C. Elwood,et al. Canadian surveillance of COVID-19 in pregnancy: Epidemiology and maternal and infant outcomes , 2020, American Journal of Obstetrics and Gynecology.
[22] Simon M. Lin,et al. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. , 2020, JAMA pediatrics.
[23] J. Schmittdiel,et al. SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California , 2020, The oncologist.
[24] Benjamin Bowe,et al. Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[25] N. López-Villalobos,et al. Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID‐19 in Mexico , 2020, Nephrology.
[26] C. Rentsch,et al. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index , 2020, PloS one.
[27] J. Pell,et al. Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank , 2020, BMC Medicine.
[28] E. Olsen,et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[29] M. Tunis,et al. Key populations for early COVID-19 immunization: preliminary guidance for policy , 2020, Canadian Medical Association Journal.
[30] R. Piccolo,et al. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection , 2020, Open Heart.
[31] Jorge Valencia,et al. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study , 2020, BMJ Open.
[32] S. Gilboa,et al. Characteristics of Women of Reproductive Age With Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status—United States, January 22–June 7, 2020 , 2020 .
[33] C. Goss,et al. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis , 2020, Journal of Cystic Fibrosis.
[34] I. Oh,et al. Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea: Analysis Using Nationwide Health Claims Data , 2020, Risk management and healthcare policy.
[35] Geun U Park,et al. Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database , 2020, International journal of environmental research and public health.
[36] M. Matrana,et al. Multivariate mortality analyses in COVID‐19: Comparing patients with cancer and patients without cancer in Louisiana , 2020, Cancer.
[37] C. Fischbacher,et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study , 2020, BMJ.
[38] Benjamin S. Glicksberg,et al. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19 , 2020, Journal of the American College of Cardiology.
[39] C. Sabin,et al. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] R. Keogh,et al. COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults , 2020, Annals of Internal Medicine.
[41] W. Ji,et al. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: A matter of sexual dimorphism? , 2020, Diabetes Research and Clinical Practice.
[42] Samantha K. Brenner,et al. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.
[43] K. Baumstarck,et al. Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study , 2020, Schizophrenia bulletin.
[44] P. Pelosi,et al. Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) , 2020, Frontiers in Cardiovascular Medicine.
[45] Kevin Y. Du,et al. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age , 2020, Journal of Ovarian Research.
[46] A. Singer,et al. Outcomes in Hispanics With COVID‐19 Are Similar to Those of Caucasian Patients in Suburban New York , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[47] S. Chilimuri,et al. Association of smoking status with outcomes in hospitalised patients with COVID-19 , 2020, BMJ open respiratory research.
[48] Surveillance.,et al. Descriptive epidemiology of deceased cases of COVID-19 reported during the initial wave of the epidemic in Canada, January 15 to July 9, 2020. , 2020, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[49] N. Kolhe,et al. Acute kidney injury associated with COVID-19: A retrospective cohort study , 2020, PLoS medicine.
[50] J. Nattermann,et al. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” , 2020, Infection.
[51] Jessica K De Freitas,et al. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records , 2020, BMJ Open.
[52] R. Kustra,et al. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study. , 2020, CMAJ open.
[53] I. Dhalla,et al. COVID-19 in long-term care homes in Ontario and British Columbia , 2020, Canadian Medical Association Journal.
[54] C. Sánchez-Piedra,et al. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients , 2020, Public Health.
[55] M. Topmiller,et al. Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database , 2020, Journal of health economics and outcomes research.
[56] I. Tanboğa,et al. The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19 , 2020, Journal of Infection.
[57] L. Guerrero-Torres,et al. Clinical Characteristics and Mortality of Healthcare Workers with SARS-CoV-2 infection in Mexico City , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] R. Gómez-Huelgas,et al. Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19 , 2020, Journal of clinical medicine.
[59] O. Mendoza-Cano,et al. COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study , 2020, Journal of global health.
[60] M. Tunis,et al. Navigating inequities: a roadmap out of the pandemic , 2020, BMJ Global Health.
[61] M. Zervos,et al. The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] Y. Ahn,et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study , 2020, The Lancet Psychiatry.
[63] U. Fresán,et al. Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study , 2020, Obesity.
[64] Benjamin S. Glicksberg,et al. AKI in Hospitalized Patients with COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.
[65] S. Kalnicki,et al. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York , 2020, JAMA network open.
[66] V. Fan,et al. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection , 2020, JAMA network open.
[67] S. Smirnakis,et al. Characteristics and Outcomes of Latinx Patients With COVID-19 in Comparison With Other Ethnic and Racial Groups , 2020, Open forum infectious diseases.
[68] P. Diggle,et al. Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area , 2020, BMJ open respiratory research.
[69] Kathleen M. Akgün,et al. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study , 2020, PLoS medicine.
[70] M. Koca,et al. Older Adults With Coronavirus Disease 2019; A Nationwide Study in Turkey , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[71] H. Wildiers,et al. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis , 2020, ESMO Open.
[72] G. Lip,et al. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis , 2020, PLoS medicine.
[73] M. Chung,et al. Impact of the COVID-19 Pandemic on Healthcare Workers’ Risk of Infection and Outcomes in a Large, Integrated Health System , 2020, Journal of General Internal Medicine.
[74] E. Taioli,et al. Male Sex, Severe Obesity, Older Age, and Chronic Kidney Disease Are Associated With COVID-19 Severity and Mortality in New York City , 2020, Chest.
[75] R. Grilli,et al. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy , 2020, PloS one.
[76] J. Zein,et al. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry , 2020, EClinicalMedicine.
[77] Javier A. Neyra,et al. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States , 2020, American Journal of Transplantation.
[78] A. Borobia,et al. Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications , 2020, European journal of heart failure.
[79] L. Liang,et al. Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data , 2020, Metabolism.
[80] S. Czernichow,et al. Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients , 2020, Obesity.
[81] M. Chung,et al. Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system. , 2020, Research square.
[82] M. Hauptmann,et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study , 2020, Clinical Microbiology and Infection.
[83] E. Genden,et al. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study , 2020, Frontiers in Endocrinology.
[84] M. Abate,et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 , 2020, Kidney International.
[85] N. López-Villalobos,et al. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico , 2020, Annals of Epidemiology.
[86] K. Khunti,et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.
[87] J. A. Leon-Abarca. Obesity and immunodeficiencies are the main pre‐existing conditions associated with mild to moderate COVID‐19 in children , 2020, Pediatric obesity.
[88] J. Skarbinski,et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization , 2020, Annals of Internal Medicine.
[89] M. Kivimäki,et al. Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom , 2020, Proceedings of the National Academy of Sciences.
[90] Tracey A. Dechert,et al. National Disparities in COVID-19 Outcomes between Black and White Americans , 2020, Journal of the National Medical Association.
[91] B. Hota,et al. Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID‐19 Patients in Chicago, Illinois , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[92] D. Podzamczer,et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain , 2020, Clinical Microbiology and Infection.
[93] S. Merler,et al. Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[94] C. Jesser,et al. Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals , 2020, JAMA network open.
[95] J. Portolés,et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[96] W. Schaffner,et al. Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System , 2020, medRxiv.
[97] E. Genden,et al. Risk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study , 2020, Journal of medical virology.
[98] M. Foracchia,et al. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia , 2020, Biology.
[99] J. Hewitt,et al. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople) , 2020, Journal of Hospital Infection.
[100] E. Eskandar,et al. A novel severity score to predict inpatient mortality in COVID-19 patients , 2020, Scientific Reports.
[101] L. Brammer,et al. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[102] Anand Srivastava,et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. , 2020, JAMA internal medicine.
[103] M. Antonelli,et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.
[104] C. Torp‐Pedersen,et al. Association between male sex and outcomes of Coronavirus Disease 2019 (Covid‐19) – a Danish nationwide, register-based study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] M. Rivas,et al. Race, socioeconomic deprivation, and hospitalization for COVID-19 in English participants of a national biobank , 2020, International Journal for Equity in Health.
[106] S. Barquera,et al. The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients , 2020, Obesity.
[107] I. Bogoch,et al. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada , 2020, JAMA network open.
[108] Y. Oymak,et al. Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study , 2020, Mediterranean journal of hematology and infectious diseases.
[109] A. Dunn,et al. Risk Factors for Mortality in Patients with COVID-19 in New York City , 2020, Journal of General Internal Medicine.
[110] S. Gilboa,et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[111] C. Murray,et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.
[112] D. Fisman,et al. Derivation and Validation of Clinical Prediction Rules for COVID-19 Mortality in Ontario, Canada , 2020, medRxiv.
[113] R. Cianci,et al. Age and Multimorbidity Predict Death Among COVID-19 Patients , 2020, Hypertension.
[114] Yoon Jung Choi,et al. Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study , 2020, Scientific Reports.
[115] E. Flamarion,et al. Prognosis of patients with sickle cell disease and COVID-19: a French experience , 2020, The Lancet Haematology.
[116] A. Peters,et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[117] G. Mufti,et al. Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience , 2020, British journal of haematology.
[118] Kelsey Young,et al. A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations , 2020, Vaccine.
[119] K. Farsalinos,et al. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases , 2020, medRxiv.
[120] W. Ji,et al. Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study , 2020, Journal of Korean medical science.
[121] C. Gale,et al. Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study , 2020, Brain, Behavior, and Immunity.
[122] Deepak L. Bhatt,et al. Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry , 2020, Mayo Clinic Proceedings.
[123] A. Hernández-Vásquez,et al. Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study , 2020, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[124] E. Price-Haywood,et al. Hospitalization and Mortality among Black Patients and White Patients with Covid-19 , 2020, The New England journal of medicine.
[125] D. Nieman. Faculty Opinions recommendation of Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. , 2020 .
[126] E. Murillo-Zamora,et al. Survival in adult inpatients with COVID-19 , 2020, Public Health.
[127] H. Sørensen,et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort , 2020, medRxiv.
[128] E. Klang,et al. Severe Obesity as an Independent Risk Factor for COVID‐19 Mortality in Hospitalized Patients Younger than 50 , 2020, Obesity.
[129] L. Mantovani,et al. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens , 2020, medRxiv.
[130] Mika Kivimäki,et al. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK , 2020, Brain, Behavior, and Immunity.
[131] P. Horby,et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.
[132] Leora I. Horwitz,et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.
[133] Kristen M J Azar,et al. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. , 2020, Health affairs.
[134] Kenar D. Jhaveri,et al. Acute kidney injury in patients hospitalized with COVID-19 , 2020, Kidney International.
[135] Benjamin R. Kummer,et al. History of Stroke Is Independently Associated With In-Hospital Death in Patients With COVID-19 , 2020, Stroke.
[136] Evan T. Sholle,et al. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications , 2020, Gastroenterology.
[137] M. Rivas,et al. Race, Socioeconomic Deprivation, and Hospitalization for COVID-19 in English participants of a National Biobank , 2020, medRxiv.
[138] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.
[139] G. Heinze,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.
[140] P. Adab,et al. Covid-19: risk factors for severe disease and death , 2020, BMJ.
[141] J. Ludvigsson. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.
[142] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.
[143] H. Schünemann,et al. Rating the certainty in evidence in the absence of a single estimate of effect , 2017, Evidence-Based Medicine.
[144] Tim Evans,et al. Road traffic crashes: operationalizing equity in the context of health sector reform , 2003, Injury control and safety promotion.
[145] A. E. Bateman. The Statistics of Canada , 1878 .